vancouver british columbia, February 16, 2024 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA) (AQSE: NARA) announces changes to its Board of Directors.
Our company has announced the resignation of a director. Vincent Lam As a director of our company. Mr. Lum, former CEO and co-founder of PanGenomic Health, will continue to serve as his CEO, president, executive chairman and director of MUJN Diagnostics Inc., a subsidiary of the Company.
We are pleased to announce the following appointments: Francisco Kent Carrasquero As a director of our company. Mr. Carrasquero previously served as Vice President of Finance and Director of the Company and has served as the Company's corporate financial consultant since its listing on the Canadian Securities Exchange.
About PanGenomic Health
PanGenomic Health is a precision health company that has developed a self-care digital platform that provides personalized, evidence-based information about natural therapies. Our initial focus is mental health support.was registered as british columbia As a benefits company, PanGenomic Health's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to each individual's health profile.
This news release contains certain statements that may be considered “forward-looking statements,” including statements regarding services provided by PanGenomic Health and consideration paid to PanGenomic Health. “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “predict”, “should”, “believe” The use of words such as '' is intended to identify forward-looking statements. Although PanGenomic Health believes that the expectations and assumptions underlying the forward-looking statements are reasonable, PanGenomic Health can give no assurance that the forward-looking statements will prove to be correct. You should not place undue reliance on forward-looking statements. Forward-looking statements refer to future events or conditions and, by their nature, involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results may not be as expected due to a number of factors and risks, including various risk factors described in his PanGenomic Health disclosure document located on his PanGenomic Health profile at www.sedarplus.ca. The results may differ significantly from those shown.
The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.
SOURCE PanGenomic Health Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2024/16/c5687.html
